We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+0.71%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$33.3B
AUM Growth
-$783M
(-2.3%)
Cap. Flow
-$715M
Cap. Flow
% of AUM
-2.15%
Top 10 Holdings %
Top 10 Hldgs %
15.9%
Holding
3,039
New
28
Increased
1,056
Reduced
1,268
Closed
57
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$29M |
| 2 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$14M |
| 3 |
Microsoft
MSFT
|
+$10.8M |
| 4 |
Meta Platforms (Facebook)
META
|
+$10.5M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
+$6.72M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$34.4M |
| 2 |
FRX
FOREST LABORATORIES INC
FRX
|
+$32.2M |
| 3 |
ExxonMobil
XOM
|
+$23.9M |
| 4 |
Warner Bros
WBD
|
+$15.4M |
| 5 |
RTX Corp
RTX
|
+$13.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.81% |
| 2 | Financials | 14.8% |
| 3 | Healthcare | 13.73% |
| 4 | Industrials | 10.72% |
| 5 | Energy | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1676
Nexstar Media Group
NXST
$5.86B
| $1.13M | ﹤0.01% |
28,064
-1,025
| -4% | -$47.6K |
|
|
KERX
1677
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $1.13M | ﹤0.01% |
82,456
-3,665
| -4% | -$56.1K |
|
|
LOGM
1678
DELISTED
LogMein, Inc.
LOGM
| $1.13M | ﹤0.01% |
24,586
-150
| -0.6% | -$6.47K |
|
1679
Empire State Realty Trust
ESRT
$848M
| $1.13M | ﹤0.01% |
75,315
-2,620
| -3% | -$42.4K |
|
1680
Neurocrine Biosciences
NBIX
$16.9B
| $1.13M | ﹤0.01% |
72,050
+1,330
| +2% | +$19.9K |
|
1681
Omnicell
OMCL
$1.71B
| $1.13M | ﹤0.01% |
41,281
| – | – |
|
|
CLD
1682
DELISTED
Cloud Peak Energy Inc
CLD
| $1.13M | ﹤0.01% |
89,275
+1,000
| +1% | +$15.1K |
|
1683
Trex
TREX
$4.69B
| $1.12M | ﹤0.01% |
129,972
-180
| -0.1% | -$1.51K |
|
|
HNGR
1684
DELISTED
Hanger Inc.
HNGR
| $1.12M | ﹤0.01% |
54,702
-500
| -0.9% | -$12.8K |
|
1685
DXP Enterprises
DXPE
$2.53B
| $1.12M | ﹤0.01% |
15,184
+330
| +2% | +$25.1K |
|
|
WAC
1686
DELISTED
Walter Investment Mgt Corp
WAC
| $1.12M | ﹤0.01% |
50,962
-830
| -2% | -$21.7K |
|
|
CSR
1687
Centerspace
CSR
$932M
| $1.12M | ﹤0.01% |
14,508
+420
| +3% | +$35.3K |
|
|
UCB
1688
United Community Banks
UCB
$4.31B
| $1.12M | ﹤0.01% |
67,778
-1,950
| -3% | -$32.4K |
|
1689
PENN Entertainment
PENN
$2.69B
| $1.11M | ﹤0.01% |
99,304
-100
| -0.1% | -$1.13K |
|
|
PDLI
1690
DELISTED
PDL BioPharma, Inc.
PDLI
| $1.11M | ﹤0.01% |
148,945
-87,200
| -37% | -$810K |
|
1691
Banner Corp
BANR
$2.41B
| $1.11M | ﹤0.01% |
28,869
-100
| -0.3% | -$3.92K |
|
1692
Regis Corp
RGS
$68.8M
| $1.11M | ﹤0.01% |
3,482
-2
| -0.1% | -$600 |
|
|
INN
1693
Summit Hotel Properties
INN
$746M
| $1.11M | ﹤0.01% |
103,011
-1,300
| -1% | -$13.9K |
|
|
MGAM
1694
DELISTED
MULTIMEDIA GAMES HOLDING COMPANY INC COM STK (TX)
MGAM
| $1.11M | ﹤0.01% |
30,807
+250
| +0.8% | +$7.52K |
|
|
PFPT
1695
DELISTED
Proofpoint, Inc.
PFPT
| $1.11M | ﹤0.01% |
29,844
-2,245
| -7% | -$83.8K |
|
|
WIRE
1696
DELISTED
Encore Wire Corp
WIRE
| $1.11M | ﹤0.01% |
29,829
+310
| +1% | +$13.5K |
|
1697
Axos Financial
AX
$5.94B
| $1.1M | ﹤0.01% |
60,560
-200
| -0.3% | -$3.77K |
|
|
WSTC
1698
DELISTED
West Corporation
WSTC
| $1.1M | ﹤0.01% |
37,387
-1,300
| -3% | -$36.6K |
|
|
RDS.B
1699
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $1.1M | ﹤0.01% |
+13,900
| New | +$1.17M |
|
|
SPTN
1700
DELISTED
SpartanNash
SPTN
| $1.1M | ﹤0.01% |
56,520
+600
| +1% | +$12.7K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2014 Portfolio in Review
As of Q3 2014, RhumbLine Advisers held 3,039 positions worth $33.3B, down 2.3% from $34.1B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q3 2014: portfolio turnover was 2.8%. RhumbLine Advisers opened 28 new positions and exited 57, leaving the 3,039-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q3 2014 buy was Discovery, Inc. Series C Common Stock: 346,925 shares worth $12.9M.
- RhumbLine Advisers added most to Allergan plc in Q3 2014, an estimated $29M increase.
- RhumbLine Advisers's biggest Q3 2014 reduction was Apple, cutting an estimated $34.4M.
- RhumbLine Advisers fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $32.2M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $33.3B portfolio in Q3 2014.
- RhumbLine Advisers opened 28 new positions and closed 57 in Q3 2014.
- RhumbLine Advisers's portfolio value fell 2.3% quarter-over-quarter to $33.3B.
Based on RhumbLine Advisers's 13F filing for Q3 2014, filed 12 Nov 2014.